Radiotherapy for patients with brain metastases and leptomeningeal carcinomatosis: prognostic factors and clinical outcomes
Clinical & Experimental Metastasis · 2025
DOI: 10.1007/s10585-025-10352-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Metastasis, 2025. Verfasst von Lena Maria Blattmann und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. Hauptthemen laut MEDLINE: Meningeal Carcinomatosis, Brain Neoplasms, Cranial Irradiation. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Herzzentrum Göttingen.
Abstract (Originalsprache)
Brain metastases and leptomeningeal carcinomatosis (LC) are complications of advanced-stage malignancies, associated with a poor prognosis. This study aimed to evaluate the role of prognostic factors and radiotherapy (RT) treatment approaches while taking toxicity into account. We performed a retrospective study and compared clinical characteristics, prognostic factors, toxicities and outcomes in patients with (1) parenchymal brain metastases (PM) ( n = 275) vs. LC ( n = 35) and (2) in patients with whole brain radiotherapy (WBRT) ( n = 52) vs. WBRT + boost ( n = 201). We found poorer survival (OS) of the LC group compared to PM patients in univariable analysis (not in multivariable analysis). LC patients predominantly underwent WBRT only, received surgical resection before RT less frequently and had more RT discontinuations than PM patients. OS was better in the WBRT + boost group than in the WBRT only group. In patients who received WBRT + boost, the primary tumor was more often controlled, and the number of PM was lower compared to the WBRT only group. WBRT + boost was associated with higher rates of alopecia than WBRT only. Patients with LC had a worse prognosis compared to patients with PM. WBRT + boost resulted in higher toxicity than WBRT only but resulted in better OS in the presented study. WBRT + boost patients had more favorable prognostic factors prior to RT, so OS improvement is not likely due to boost. Treating brain metastases requires a careful assessment of benefits and risks. Optimal RT planning should consider prognostic factors and potential side effects individually.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
- Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Germany.
- Department of Neurosurgery, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
- Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. hendrik.droege@med.uni-goettingen.de.
- Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Germany. hendrik.droege@med.uni-goettingen.de.
ORCID-Profile: Leif Hendrik Dröge
Förderung
- Herzzentrum Göttingen
Zitieren
APA
Blattmann, L. M., Shafie, R. E., Bendrich, S., Donath, S., Knaus, O., Hille, A., Abboud, T., Guhlich, M., Leu, M., Schirmer, M. A., Anczykowski, M. Z., Fischer, L. A., Kieslich, B., Jung, P., Rieken, S., Zwerenz, C. M., & Dröge, L. H. (2025). Radiotherapy for patients with brain metastases and leptomeningeal carcinomatosis: prognostic factors and clinical outcomes. Clinical & Experimental Metastasis. https://doi.org/10.1007/s10585-025-10352-3
Vancouver
Blattmann LM, Shafie RE, Bendrich S, Donath S, Knaus O, Hille A, et al. Radiotherapy for patients with brain metastases and leptomeningeal carcinomatosis: prognostic factors and clinical outcomes. Clinical & Experimental Metastasis. 2025. doi:10.1007/s10585-025-10352-3
BibTeX
@article{Blattmann2025,
author = {Blattmann, Lena Maria and Shafie, Rami El and Bendrich, Stephanie and Donath, Sandra and Knaus, Olga and Hille, Andrea and Abboud, Tammam and Guhlich, Manuel and Leu, Martin and Schirmer, Markus Anton and Anczykowski, Mahalia Zoe and Fischer, Laura Anna and Kieslich, Benedikt and Jung, Philipp and Rieken, Stefan and Zwerenz, Carla Marie and Dröge, Leif Hendrik},
title = {Radiotherapy for patients with brain metastases and leptomeningeal carcinomatosis: prognostic factors and clinical outcomes},
journal = {Clinical & Experimental Metastasis},
year = {2025},
doi = {10.1007/s10585-025-10352-3}
}
EUVIMED